Found: 7
Select item for more details and to access through your institution.
Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families.
- Published in:
- Dermatology & Therapy, 2018, v. 8, n. 4, p. 605, doi. 10.1007/s13555-018-0263-0
- By:
- Publication type:
- Article
Clinician vs Self-ratings of Hirsutism in Patients With Polycystic Ovarian Syndrome: Associations With Quality of Life and Depression.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Crisaborole Topical Ointment, 2% in Patients Ages 2 to 17 Years with Atopic Dermatitis: A Phase 1b, Open-Label, Maximal-Use Systemic Exposure Study.
- Published in:
- Pediatric Dermatology, 2016, v. 33, n. 4, p. 380, doi. 10.1111/pde.12872
- By:
- Publication type:
- Article
Pharmacokinetic Profile, Safety, and Tolerability of Crisaborole Topical Ointment, 2% in Adolescents with Atopic Dermatitis: An Open-Label Phase 2a Study.
- Published in:
- Pediatric Dermatology, 2016, v. 33, n. 2, p. 150, doi. 10.1111/pde.12780
- By:
- Publication type:
- Article
Dermatologic Manifestations of Polycystic Ovary Syndrome.
- Published in:
- American Journal of Clinical Dermatology, 2007, v. 8, n. 4, p. 201, doi. 10.2165/00128071-200708040-00003
- By:
- Publication type:
- Article
Early Relief of Pruritus in Atopic Dermatitis with Crisaborole Ointment, A Non-steroidal, Phosphodiesterase 4 Inhibitor.
- Published in:
- Acta Dermato-Venereologica, 2018, v. 98, n. 5, p. 484, doi. 10.2340/00015555-2893
- By:
- Publication type:
- Article